Search Results

Filter
  • 1-10 of  114 results for ""Oxidopamine""
Item request has been placed! ×
Item request cannot be made. ×
loading  Processing Request
Academic Journal

Rosiglitazone, a PPAR-γ agonist, protects against striatal dopaminergic neurodegeneration induced by 6-OHDA lesions in the substantia nigra of rats.

  • Authors : Lee EY; Department of Pharmacology, College of Medicine, Hanyang University, 133-791 Seoul, Republic of Korea.; Lee JE

Subjects: Nerve Degeneration* ; Oxidopamine*; Basal Ganglia/Basal Ganglia/Basal Ganglia/*drug effects

  • Source: Toxicology letters [Toxicol Lett] 2012 Sep 18; Vol. 213 (3), pp. 332-44. Date of Electronic Publication: 2012 Jul 27.Publisher: Elsevier Country of Publication: Netherlands NLM ID: 7709027 Publication Model: Print-Electronic Cited Medium: Internet ISSN:

Record details

×
Academic Journal

Time-course of nigrostriatal damage, basal ganglia metabolic changes and behavioural alterations following intrastriatal injection of 6-hydroxydopamine in the rat: new clues from an old model.

  • Authors : Blandini F; Laboratory of Functional Neurochemistry, IRCCS Neurological Institute C. Mondino, Pavia, Italy. ; Levandis G

Subjects: Basal Ganglia*/Basal Ganglia*/Basal Ganglia*/drug effects ; Basal Ganglia*/Basal Ganglia*/Basal Ganglia*/metabolism ; Basal Ganglia*/Basal Ganglia*/Basal Ganglia*/pathology

  • Source: The European journal of neuroscience [Eur J Neurosci] 2007 Jan; Vol. 25 (2), pp. 397-405.Publisher: Wiley-Blackwell Country of Publication: France NLM ID: 8918110 Publication Model: Print Cited Medium: Print ISSN: 0953-816X (Print)

Record details

×
Academic Journal

Dopamine agonist-mediated rotation in rats with unilateral nigrostriatal lesions is not dependent on net inhibitions of rate in basal ganglia output nuclei.

  • Authors : Ruskin DN; Experimental Therapeutics Branch, National Institute of Neurological Disorders and Stroke, National Institutes of Health, Bethesda, MD 20892-1406, USA.; Bergstrom DA

Subjects: Dopamine Agonists*/Dopamine Agonists*/Dopamine Agonists*/pharmacology ; Oxidopamine*/Oxidopamine*/Oxidopamine*/pharmacology; Basal Ganglia/Basal Ganglia/Basal Ganglia/*physiology

  • Source: Neuroscience [Neuroscience] 1999; Vol. 91 (3), pp. 935-46.Publisher: Elsevier Science Country of Publication: United States NLM ID: 7605074 Publication Model: Print Cited Medium: Print ISSN: 0306-4522

Record details

×
Academic Journal

Changes of amino acid and monoamine levels after neonatal 6-hydroxydopamine denervation in rat basal ganglia, substantia nigra, and Raphe nuclei.

  • Authors : Molina-Holgado E; Département de Physiologie, Faculté de Médecine, Université de Montréal, Quebec, Canada.; Dewar KM

Subjects: Amino Acids/Amino Acids/Amino Acids/*metabolism ; Basal Ganglia/Basal Ganglia/Basal Ganglia/*metabolism ; Biogenic Monoamines/Biogenic Monoamines/Biogenic Monoamines/*metabolism

  • Source: Journal of neuroscience research [J Neurosci Res] 1993 Jul 01; Vol. 35 (4), pp. 409-18.Publisher: Wiley Interscience Country of Publication: United States NLM ID: 7600111 Publication Model: Print Cited Medium: Print ISSN: 0360-4012

Record details

×
Academic Journal

Ether-à-go-go 1 (Eag1) potassium channel expression in dopaminergic neurons of basal ganglia is modulated by 6-hydroxydopamine lesion.

  • Authors : Ferreira NR; Department of Physiology, School of Medicine, Campus USP, Ribeirão Preto, SP, Brazil.; Mitkovski M

Subjects: Basal Ganglia/Basal Ganglia/Basal Ganglia/*metabolism ; Dopaminergic Neurons/Dopaminergic Neurons/Dopaminergic Neurons/*metabolism ; Ether-A-Go-Go Potassium Channels/Ether-A-Go-Go Potassium Channels/Ether-A-Go-Go Potassium Channels/*metabolism

  • Source: Neurotoxicity research [Neurotox Res] 2012 Apr; Vol. 21 (3), pp. 317-33. Date of Electronic Publication: 2011 Nov 03.Publisher: Springer Country of Publication: United States NLM ID: 100929017 Publication Model: Print-Electronic Cited Medium: Internet ISSN:

Record details

×
Academic Journal

Proteomic characterization of the striatum and midbrain treated with 6-hydroxydopamine: alteration of 58-kDa glucose-regulated protein and C/EBP homologous protein.

  • Authors : Akazawa YO; Health Technology Research Center, National Institute of Advanced Industrial Science and Technology (AIST), Kansai Center, Ikeda, Osaka, Japan.; Saito Y

Subjects: Proteomics*/Proteomics*/Proteomics*/methods; Basal Ganglia/Basal Ganglia/Basal Ganglia/*drug effects ; Mesencephalon/Mesencephalon/Mesencephalon/*drug effects

  • Source: Free radical research [Free Radic Res] 2010 Apr; Vol. 44 (4), pp. 410-21.Publisher: Informa Healthcare Country of Publication: England NLM ID: 9423872 Publication Model: Print Cited Medium: Internet ISSN: 1029-2470

Record details

×
Academic Journal

Effects of unilateral 6-hydroxydopamine lesions on neuropeptide immunoreactivity in the basal ganglia of the common marmoset, Callithrix jacchus, a quantitative immunohistochemical analysis.

  • Authors : Roeling TA; Department of Anatomy and Embryology, Vrije Universiteit, Faculty of Medicine, Graduate School Neurosciences, Amsterdam, The Netherlands.; Docter GJ

Subjects: Basal Ganglia/Basal Ganglia/Basal Ganglia/*metabolism ; Dopamine/Dopamine/Dopamine/*physiology ; Neuropeptides/Neuropeptides/Neuropeptides/*metabolism

  • Source: Journal of chemical neuroanatomy [J Chem Neuroanat] 1995 Oct; Vol. 9 (3), pp. 155-64.Publisher: Elsevier Science Publisher Country of Publication: Netherlands NLM ID: 8902615 Publication Model: Print Cited Medium: Print ISSN:

Record details

×
Academic Journal

Dopaminergic denervation impairs cortical motor and associative/limbic information processing through the basal ganglia and its modulation by the CB1 receptor.

  • Authors : Antonazzo M; Department of Pharmacology, Faculty of Medicine and Nursing, University of the Basque Country (UPV/EHU), Leioa 48940, Spain; Neurodegenerative diseases Group, Biocruces Health Research Institute, Barakaldo, Bizkaia, Spain.

Subjects: Basal Ganglia/Basal Ganglia/Basal Ganglia/*metabolism ; Dopamine/Dopamine/Dopamine/*metabolism ; Limbic System/Limbic System/Limbic System/*metabolism

  • Source: Neurobiology of disease [Neurobiol Dis] 2021 Jan; Vol. 148, pp. 105214. Date of Electronic Publication: 2020 Dec 03.Publisher: Academic Press Country of Publication: United States NLM ID: 9500169 Publication Model: Print-Electronic Cited Medium: Internet ISSN:

Record details

×
Academic Journal

A chemogenetic approach for treating experimental Parkinson's disease.

  • Authors : Assaf F; The Rappaport Faculty of Medicine, Technion-Israel Institute of Technology, Haifa, Israel.; Schiller Y

Subjects: Basal Ganglia/Basal Ganglia/Basal Ganglia/*drug effects ; Clozapine/Clozapine/Clozapine/*analogs & derivatives ; Motor Activity/Motor Activity/Motor Activity/*drug effects

  • Source: Movement disorders : official journal of the Movement Disorder Society [Mov Disord] 2019 Apr; Vol. 34 (4), pp. 469-479. Date of Electronic Publication: 2018 Dec 10.Publisher: Wiley-Liss Country of Publication: United States NLM ID: 8610688 Publication Model: Print-Electronic Cited Medium: Internet ISSN:

Record details

×
Academic Journal

Propagation of beta/gamma rhythms in the cortico-basal ganglia circuits of the parkinsonian rat.

  • Authors : West TO; Centre for Mathematics and Physics in the Life Sciences and Experimental Biology (CoMPLEX), Department of Physics and Astronomy, University College London , London , United Kingdom.; Wellcome Trust Centre for Neuroimaging, Institute of Neurology, University College London , London , United Kingdom.

Subjects: Basal Ganglia/Basal Ganglia/Basal Ganglia/*physiopathology ; Beta Rhythm/Beta Rhythm/Beta Rhythm/*physiology ; Cerebral Cortex/Cerebral Cortex/Cerebral Cortex/*physiopathology

  • Source: Journal of neurophysiology [J Neurophysiol] 2018 May 01; Vol. 119 (5), pp. 1608-1628. Date of Electronic Publication: 2018 Jan 10.Publisher: American Physiological Society Country of Publication: United States NLM ID: 0375404 Publication Model: Print-Electronic Cited Medium:

Record details

×
  • 1-10 of  114 results for ""Oxidopamine""